Company profile
Ymmunobio company profile
Ymmunobio is a preclinical-stage oncology biotech startup committed to creating advanced cancer patient treatments. It makes extensive progress in developing antibodies that have an influence on the immune system by reinstating its immune response to cancers or directly inhibiting cancer cell proliferation.
Business identity
- Website
- https://www.ymmunobio.com
- Operating status
- Active
- Company type
- For Profit
- Employee range
- 1-10 employees
- Revenue range
- $0-$1M
- Founded
- 2021-01-01, Year
Headquarters
- Headquarters
- Breíl, Grisons, Switzerland
- Country code
- CH
- Continent
- Europe